Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Erik Roys is active.

Publication


Featured researches published by Erik Roys.


Seminars in Dialysis | 2003

The Longitudinal Chronic Kidney Disease Study: A Prospective Cohort Study of Predialysis Renal Failure

Rachel L. Perlman; Margaret Kiser; Fredric O. Finkelstein; George Eisele; Erik Roys; Lei Liu; Sally Burrows-Hudson; Friedrich Port; Joseph M. Messana; George R. Bailie; Sanjay Rajagopalan; Rajiv Saran

Chronic kidney disease (CKD) is a significant public health problem: every year the number of Americans living with CKD and requiring renal replacement therapy increases. In addition, individuals with CKD have substantially increased morbidity and mortality compared to the general population. The Longitudinal Chronic Kidney Dialysis (LCKD) Study is a multicenter, prospective, observational study of patients with moderate to severe CKD that was designed to better describe the course of the disease and the determinants of patient outcomes. Patients with moderate to severe CKD (glomerular filtration rate [GFR] < 60 ml/min/m2) from four academic nephrology clinics were enrolled between 2000 and 2002. Special cardiac and vascular testing has recently commenced as phase II of this study. Areas that have been or are currently being studied include anemia management, health‐related quality of life (HRQOL), medication use, and markers of cardiovascular disease. This article describes the LCKD Study in the context of current knowledge of CKD.


Journal of The American Society of Nephrology | 2005

Economic Impact of Case-Mix Adjusting the Dialysis Composite Rate

Richard A. Hirth; Erik Roys; John R. C. Wheeler; Joseph M. Messana; Marc N. Turenne; Rajiv Saran; Alyssa S. Pozniak; Robert A. Wolfe

The Medicare program reimburses dialysis providers a flat rate for a bundle of services that comprise the basic dialysis treatment. This payment system is being modified to incorporate case-mix adjustment for age and body size, which have been shown to influence dialysis costs. This study simulated the economic impact of the recently issued Medicare rule on case-mix adjustment by estimating the variation in payments across patients, facilities, and broad classes of facilities. Case-mix adjustment results in considerable patient-level variation in payments (dollar 12.99 SD in case-mix adjusted payments). The variation across dialysis facilities is smaller but still economically significant (dollar 3.77 SD). However, there was little evidence that particular classes of facilities (e.g., ownership, chain membership, size) will be substantially advantaged or disadvantaged by case-mix adjustment. There do seem to be modest changes in the regional distribution of payments.


Infection Control and Hospital Epidemiology | 2015

Variation in Infection Prevention Practices in Dialysis Facilities: Results from the National Opportunity to Improve Infection Control in ESRD (End-Stage Renal Disease) Project

Carol E. Chenoweth; Stephen C. Hines; Kendall K. Hall; Rajiv Saran; John D. Kalbfleisch; Teri Spencer; Kelly M. Frank; Diane Carlson; Jan Deane; Erik Roys; Natalie Scholz; Casey Parrotte; Joseph M. Messana

OBJECTIVE To observe patient care across hemodialysis facilities enrolled in the National Opportunity to Improve Infection Control in ESRD (end-stage renal disease) (NOTICE) project in order to evaluate adherence to evidence-based practices aimed at prevention of infection. SETTING AND PARTICIPANTS Thirty-four hemodialysis facilities were randomly selected from among 772 facilities in 4 end-stage renal disease participating networks. Facility selection was stratified on dialysis organization affiliation, size, socioeconomic status, and urban/rural status. MEASUREMENTS Trained infection control evaluators used an infection control worksheet to observe 73 distinct infection control practices at the hemodialysis facilities, from October 1, 2011, through January 31, 2012. RESULTS There was considerable variation in infection control practices across enrolled facilities. Overall adherence to recommended practices was 68% (range, 45%-92%) across all facilities. Overall adherence to expected hand hygiene practice was 72% (range, 10%-100%). Compliance to hand hygiene before and after procedures was high; however, during procedures hand hygiene compliance averaged 58%. Use of chlorhexidine as the specific agent for exit site care was 19% overall but varied from 0% to 35% by facility type. The 8 checklists varied in the frequency of perfect performance from 0% for meeting every item on the checklist for disinfection practices to 22% on the arteriovenous access practices at initiation. CONCLUSIONS Our findings suggest that there are many areas for improvement in hand hygiene and other infection prevention practices in end-stage renal disease. These NOTICE project findings will help inform the development of a larger quality improvement initiative at dialysis facilities.


Journal of The American Society of Nephrology | 2002

Dialysis Dose and Body Mass Index Are Strongly Associated with Survival in Hemodialysis Patients

Friedrich K. Port; Valarie B. Ashby; Rajnish K. Dhingra; Erik Roys; Robert A. Wolfe


American Journal of Kidney Diseases | 2005

Quality of life in Chronic Kidney Disease (CKD): A cross-sectional analysis in the Renal Research Institute-CKD study

Rachel L. Perlman; Fredric O. Finkelstein; Lei Liu; Erik Roys; Margaret Kiser; George Eisele; Sally Burrows-Hudson; Joseph M. Messana; Nathan W. Levin; Sanjay Rajagopalan; Friedrich K. Port; Robert A. Wolfe; Rajiv Saran


Kidney International | 2002

Tailoring the initial vascular access for dialysis patients

Klaus Konner; Tempie E. Hulbert-Shearon; Erik Roys; Friedrich K. Port


Nephrology Dialysis Transplantation | 2005

Patterns of medication use in the RRI-CKD study : focus on medications with cardiovascular effects

George R. Bailie; George Eisele; Lei Liu; Erik Roys; Margaret Kiser; Frederick Finkelstein; Robert R. Wolfe; Friedrich K. Port; Sally Burrows-Hudson; Rajiv Saran


Kidney International | 2000

Cross-sectional and longitudinal predictors of serum albumin in hemodialysis patients

Sean F. Leavey; Robert L. Strawderman; Eric W. Young; Rajiv Saran; Erik Roys; Lawrence Y. Agodoa; Robert A. Wolfe; Friedrich K. Port


American Journal of Kidney Diseases | 2001

Use of ACE inhibitors is associated with prolonged survival of arteriovenous grafts

Robert Gradzki; Rajnish K. Dhingra; Friedrich K. Port; Erik Roys; William F. Weitzel; Joseph M. Messana


American Journal of Kidney Diseases | 1999

Introduction to the excerpts from the United States Renal Data System 1999 Annual Data Report.

Robert A. Wolfe; Friedrich K. Port; Randall L. Webb; Wendy E. Bloembergen; Richard A. Hirth; Eric W. Young; Akinlolu Ojo; Robert L. Strawderman; Rulan S. Parekh; Austin G. Stack; Philip J. Tedeschi; Tempie E. Hulbert-Shearon; Valarie B. Ashby; Sandra Callard; Julie A. Hanson; Arvind Jain; Angela Meyers-Purkiss; Erik Roys; Pamela Brown; John R. C. Wheeler; Camille A. Jones; Joel W. Greer; Lawrence Y. Agodoa

Collaboration


Dive into the Erik Roys's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Robert A. Wolfe

Beth Israel Medical Center

View shared research outputs
Top Co-Authors

Avatar

Rajiv Saran

University of Michigan

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Lei Liu

University of Michigan

View shared research outputs
Top Co-Authors

Avatar

Margaret Kiser

University of North Carolina at Chapel Hill

View shared research outputs
Researchain Logo
Decentralizing Knowledge